High Tower Advisors, LLC Sorrento Therapeutics, Inc. Call Options Transaction History

High Tower Advisors, LLC

8 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q2 2022 Aug 10, 2022	BUY	$1.24 - $2.33 $101,022 - $189,825	81,470 Added 15371.7%	82,000 $33,000
Q1 2022 May 12, 2022	SELL	$2.0 - $4.9 $104,740 - $256,613	-52,370 Reduced 99.0%	530 $24,000
Q2 2021 Aug 06, 2021	BUY	$6.35 - $10.0 $334,327 - $526,500	52,650 Added 21060.0%	52,900 $51,000
Q4 2020 Feb 10, 2021	SELL	$5.76 - $11.95 $27,360 - $56,762	-4,750 Reduced 95.0%	250 $24,000
Q3 2020 Nov 13, 2020	SELL	$6.17 - $18.82 $18,510 - $56,460	-3,000 Reduced 37.5%	5,000 $7,000
Q2 2020 Aug 10, 2020	SELL	$1.73 - $6.76 $10,380 - $40,560	-6,000 Reduced 42.86%	8,000 $17,000
Q1 2020 May 21, 2020	SELL	$1.57 - $4.76 $29,830 - $90,440	-19,000 Reduced 57.58%	14,000 $5,000
Q4 2019 Feb 14, 2020	BUY	$1.45 - $4.17 $47,850 - $137,610	33,000 New	33,000 $9,000

5.48M

Ticker SRNE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 449,952,000
Market Cap $148M
Description
Sorrento Therapeutics, Inc., a clinical stage and commercial biopharmaceutical company, develops therapies for cancer, autoimmune, inflammatory, viral, and neurodegenerative diseases. It operates through two segments, Sorrento Therapeutics and Scilex. The company provides cancer therapeutic by leveraging its proprietary G-MAB antibody library an...

Get notified when there are updates to the investment portfolio of High Tower Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on High Tower Advisors, LLC with notifications on news.